drugset / Trial / NCT01595620

Cannabinoid Modulation of Pain

NCT01595620 ↗

Phase 0 Completed 6 enrolled Yale University
RandomizedCrossoverQuadruple-blindHealth-services research

Summary

The purpose of this study is to test the effects of cannabinoids on pain response using a variety of human experimental pain models.

Timeline

Start
2011-11-09
Primary completion
2012-04-19
Completion
2012-04-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator THC Unknown 0.01 mg/kg —
Comparator THC Unknown 0.03 mg/kg —

Indications

No indication recorded.